xSPECT, the difference between seeing and knowing.
Symbia Intevo™1 the world’s first xSPECT1 system, provides physicians with the potential to not only image disease, but also leverage the high resolution to see the unseen for more confident interpretations. Its unique quantitative1capabilities may provide the ability to monitor and adjust treatments earlier by accurately measuring even small differences. To support patient safety and increased efficiency, Symbia Intevo was designed to administer the lowest2 dose while imaging patients faster than ever.
1Symbia Intevo, xSPECT, xSPECT Bone and xSPECT Quant are not licensed according to Canadian law, are pending 510(k) clearance,and are not yet commercially available in the United States or in all countries worldwide. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
2Lowest dose possible with CARE Dose4D, Autoform and flexible kV protocols.
3Based on competitive literature available at time of publication. Data on file.